Close Menu

Immunoassays

News on immunoassay systems and applications.

The Life Sciences business grew 10 percent year over year, while the Diagnostics business inched up 1 percent.

The company said it has faced competitive pressures in its diagnostics business, partially offset by organizational streamlining efforts it initiated last year.

The deal will bring together the companies' respective multiplexed immunofluorescence immunohistochemistry and digital image analysis technologies.

Researchers identified a handful of microbes associated with spontaneous preterm birth, and highlighted host immune protein levels with potential ties to the condition.

The company posted Q4 revenues of $10.9 million, up from $6.6 million in Q4 2017, beating the consensus Wall Street estimate of $9.3 million.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.